nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—SLC6A4—chronic obstructive pulmonary disease	0.416	1	CbGaD
Tramadol—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.11	0.342	CbGbCtD
Tramadol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.036	0.112	CbGbCtD
Tramadol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.036	0.112	CbGbCtD
Tramadol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0321	0.0999	CbGbCtD
Tramadol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0302	0.0941	CbGbCtD
Tramadol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0204	0.0635	CbGbCtD
Tramadol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0195	0.0606	CbGbCtD
Tramadol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0174	0.054	CbGbCtD
Tramadol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0102	0.0317	CbGbCtD
Tramadol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00962	0.0299	CbGbCtD
Tramadol—Dextromethorphan—CHRNA3—chronic obstructive pulmonary disease	0.00213	0.493	CrCbGaD
Tramadol—Venlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.00152	0.353	CrCbGaD
Tramadol—Dextromethorphan—SLC6A4—chronic obstructive pulmonary disease	0.000667	0.154	CrCbGaD
Tramadol—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000488	CcSEcCtD
Tramadol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000487	CcSEcCtD
Tramadol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000487	CcSEcCtD
Tramadol—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000486	CcSEcCtD
Tramadol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000483	CcSEcCtD
Tramadol—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000481	CcSEcCtD
Tramadol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000479	CcSEcCtD
Tramadol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000476	CcSEcCtD
Tramadol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000474	CcSEcCtD
Tramadol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000474	CcSEcCtD
Tramadol—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000474	CcSEcCtD
Tramadol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000106	0.000472	CcSEcCtD
Tramadol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000471	CcSEcCtD
Tramadol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000471	CcSEcCtD
Tramadol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00047	CcSEcCtD
Tramadol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000468	CcSEcCtD
Tramadol—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000467	CcSEcCtD
Tramadol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000465	CcSEcCtD
Tramadol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000463	CcSEcCtD
Tramadol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000463	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000462	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000462	CcSEcCtD
Tramadol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000459	CcSEcCtD
Tramadol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000459	CcSEcCtD
Tramadol—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000457	CcSEcCtD
Tramadol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000456	CcSEcCtD
Tramadol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000454	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000453	CcSEcCtD
Tramadol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000452	CcSEcCtD
Tramadol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000452	CcSEcCtD
Tramadol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000451	CcSEcCtD
Tramadol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000451	CcSEcCtD
Tramadol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00045	CcSEcCtD
Tramadol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000448	CcSEcCtD
Tramadol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000447	CcSEcCtD
Tramadol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000447	CcSEcCtD
Tramadol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000446	CcSEcCtD
Tramadol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0001	0.000445	CcSEcCtD
Tramadol—Injury—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000442	CcSEcCtD
Tramadol—Somnolence—Montelukast—chronic obstructive pulmonary disease	9.97e-05	0.000442	CcSEcCtD
Tramadol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	9.95e-05	0.000441	CcSEcCtD
Tramadol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.000438	CcSEcCtD
Tramadol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.000438	CcSEcCtD
Tramadol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	9.87e-05	0.000437	CcSEcCtD
Tramadol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	9.87e-05	0.000437	CcSEcCtD
Tramadol—Fatigue—Formoterol—chronic obstructive pulmonary disease	9.87e-05	0.000437	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	9.85e-05	0.000437	CcSEcCtD
Tramadol—Pain—Arformoterol—chronic obstructive pulmonary disease	9.79e-05	0.000434	CcSEcCtD
Tramadol—Pain—Formoterol—chronic obstructive pulmonary disease	9.79e-05	0.000434	CcSEcCtD
Tramadol—Constipation—Formoterol—chronic obstructive pulmonary disease	9.79e-05	0.000434	CcSEcCtD
Tramadol—Constipation—Arformoterol—chronic obstructive pulmonary disease	9.79e-05	0.000434	CcSEcCtD
Tramadol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.78e-05	0.000433	CcSEcCtD
Tramadol—Increased appetite—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000432	CcSEcCtD
Tramadol—Amnesia—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000432	CcSEcCtD
Tramadol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	9.71e-05	0.00043	CcSEcCtD
Tramadol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	9.69e-05	0.000429	CcSEcCtD
Tramadol—Fatigue—Montelukast—chronic obstructive pulmonary disease	9.67e-05	0.000428	CcSEcCtD
Tramadol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	9.64e-05	0.000427	CcSEcCtD
Tramadol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	9.61e-05	0.000426	CcSEcCtD
Tramadol—Pain—Montelukast—chronic obstructive pulmonary disease	9.59e-05	0.000425	CcSEcCtD
Tramadol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	9.59e-05	0.000425	CcSEcCtD
Tramadol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	9.57e-05	0.000424	CcSEcCtD
Tramadol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	9.53e-05	0.000422	CcSEcCtD
Tramadol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	9.52e-05	0.000422	CcSEcCtD
Tramadol—Purpura—Prednisone—chronic obstructive pulmonary disease	9.51e-05	0.000422	CcSEcCtD
Tramadol—Rash—Aminophylline—chronic obstructive pulmonary disease	9.49e-05	0.00042	CcSEcCtD
Tramadol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.48e-05	0.00042	CcSEcCtD
Tramadol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	9.45e-05	0.000419	CcSEcCtD
Tramadol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.44e-05	0.000418	CcSEcCtD
Tramadol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.44e-05	0.000418	CcSEcCtD
Tramadol—Headache—Aminophylline—chronic obstructive pulmonary disease	9.43e-05	0.000418	CcSEcCtD
Tramadol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	9.4e-05	0.000416	CcSEcCtD
Tramadol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.38e-05	0.000416	CcSEcCtD
Tramadol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.37e-05	0.000415	CcSEcCtD
Tramadol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.37e-05	0.000415	CcSEcCtD
Tramadol—Lethargy—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.000415	CcSEcCtD
Tramadol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.34e-05	0.000414	CcSEcCtD
Tramadol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.32e-05	0.000413	CcSEcCtD
Tramadol—Pain—Salbutamol—chronic obstructive pulmonary disease	9.25e-05	0.00041	CcSEcCtD
Tramadol—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.25e-05	0.00041	CcSEcCtD
Tramadol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.17e-05	0.000406	CcSEcCtD
Tramadol—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000406	CcSEcCtD
Tramadol—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000406	CcSEcCtD
Tramadol—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.1e-05	0.000403	CcSEcCtD
Tramadol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.1e-05	0.000403	CcSEcCtD
Tramadol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.05e-05	0.000401	CcSEcCtD
Tramadol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.05e-05	0.000401	CcSEcCtD
Tramadol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.05e-05	0.000401	CcSEcCtD
Tramadol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.05e-05	0.000401	CcSEcCtD
Tramadol—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.03e-05	0.0004	CcSEcCtD
Tramadol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.02e-05	0.0004	CcSEcCtD
Tramadol—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000397	CcSEcCtD
Tramadol—Rash—Tiotropium—chronic obstructive pulmonary disease	8.95e-05	0.000396	CcSEcCtD
Tramadol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	8.94e-05	0.000396	CcSEcCtD
Tramadol—Nausea—Aminophylline—chronic obstructive pulmonary disease	8.94e-05	0.000396	CcSEcCtD
Tramadol—Urticaria—Montelukast—chronic obstructive pulmonary disease	8.91e-05	0.000395	CcSEcCtD
Tramadol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	8.91e-05	0.000395	CcSEcCtD
Tramadol—Headache—Tiotropium—chronic obstructive pulmonary disease	8.89e-05	0.000394	CcSEcCtD
Tramadol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	8.89e-05	0.000394	CcSEcCtD
Tramadol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	8.87e-05	0.000393	CcSEcCtD
Tramadol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	8.87e-05	0.000393	CcSEcCtD
Tramadol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	8.84e-05	0.000392	CcSEcCtD
Tramadol—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000389	CcSEcCtD
Tramadol—Irritability—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000388	CcSEcCtD
Tramadol—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	8.73e-05	0.000387	CcSEcCtD
Tramadol—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000385	CcSEcCtD
Tramadol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.59e-05	0.000381	CcSEcCtD
Tramadol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.55e-05	0.000379	CcSEcCtD
Tramadol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.55e-05	0.000379	CcSEcCtD
Tramadol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.44e-05	0.000374	CcSEcCtD
Tramadol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.44e-05	0.000374	CcSEcCtD
Tramadol—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.43e-05	0.000373	CcSEcCtD
Tramadol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.41e-05	0.000373	CcSEcCtD
Tramadol—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000372	CcSEcCtD
Tramadol—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.00037	CcSEcCtD
Tramadol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.27e-05	0.000366	CcSEcCtD
Tramadol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.22e-05	0.000364	CcSEcCtD
Tramadol—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.22e-05	0.000364	CcSEcCtD
Tramadol—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.1e-05	0.000359	CcSEcCtD
Tramadol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.1e-05	0.000359	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000358	CcSEcCtD
Tramadol—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000358	CcSEcCtD
Tramadol—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.05e-05	0.000357	CcSEcCtD
Tramadol—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000354	CcSEcCtD
Tramadol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	7.97e-05	0.000353	CcSEcCtD
Tramadol—Pruritus—Montelukast—chronic obstructive pulmonary disease	7.94e-05	0.000352	CcSEcCtD
Tramadol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	7.84e-05	0.000347	CcSEcCtD
Tramadol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	7.84e-05	0.000347	CcSEcCtD
Tramadol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	7.8e-05	0.000346	CcSEcCtD
Tramadol—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000344	CcSEcCtD
Tramadol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.76e-05	0.000344	CcSEcCtD
Tramadol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000342	CcSEcCtD
Tramadol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.68e-05	0.00034	CcSEcCtD
Tramadol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.65e-05	0.000339	CcSEcCtD
Tramadol—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.6e-05	0.000337	CcSEcCtD
Tramadol—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.57e-05	0.000336	CcSEcCtD
Tramadol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.57e-05	0.000336	CcSEcCtD
Tramadol—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.42e-05	0.000329	CcSEcCtD
Tramadol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.4e-05	0.000328	CcSEcCtD
Tramadol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000323	CcSEcCtD
Tramadol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.28e-05	0.000323	CcSEcCtD
Tramadol—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.28e-05	0.000323	CcSEcCtD
Tramadol—Rash—Formoterol—chronic obstructive pulmonary disease	7.22e-05	0.00032	CcSEcCtD
Tramadol—Rash—Arformoterol—chronic obstructive pulmonary disease	7.22e-05	0.00032	CcSEcCtD
Tramadol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.21e-05	0.00032	CcSEcCtD
Tramadol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.21e-05	0.00032	CcSEcCtD
Tramadol—Headache—Formoterol—chronic obstructive pulmonary disease	7.18e-05	0.000318	CcSEcCtD
Tramadol—Headache—Arformoterol—chronic obstructive pulmonary disease	7.18e-05	0.000318	CcSEcCtD
Tramadol—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.17e-05	0.000318	CcSEcCtD
Tramadol—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.16e-05	0.000317	CcSEcCtD
Tramadol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.15e-05	0.000317	CcSEcCtD
Tramadol—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.15e-05	0.000317	CcSEcCtD
Tramadol—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.13e-05	0.000316	CcSEcCtD
Tramadol—Rash—Montelukast—chronic obstructive pulmonary disease	7.07e-05	0.000313	CcSEcCtD
Tramadol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.07e-05	0.000313	CcSEcCtD
Tramadol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.05e-05	0.000312	CcSEcCtD
Tramadol—Depression—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000312	CcSEcCtD
Tramadol—Headache—Montelukast—chronic obstructive pulmonary disease	7.03e-05	0.000311	CcSEcCtD
Tramadol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000309	CcSEcCtD
Tramadol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	6.94e-05	0.000308	CcSEcCtD
Tramadol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000307	CcSEcCtD
Tramadol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.88e-05	0.000305	CcSEcCtD
Tramadol—Malaise—Prednisolone—chronic obstructive pulmonary disease	6.85e-05	0.000304	CcSEcCtD
Tramadol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.83e-05	0.000303	CcSEcCtD
Tramadol—Rash—Salbutamol—chronic obstructive pulmonary disease	6.82e-05	0.000302	CcSEcCtD
Tramadol—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.82e-05	0.000302	CcSEcCtD
Tramadol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.81e-05	0.000302	CcSEcCtD
Tramadol—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.8e-05	0.000301	CcSEcCtD
Tramadol—Nausea—Formoterol—chronic obstructive pulmonary disease	6.8e-05	0.000301	CcSEcCtD
Tramadol—Headache—Salbutamol—chronic obstructive pulmonary disease	6.77e-05	0.0003	CcSEcCtD
Tramadol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.68e-05	0.000296	CcSEcCtD
Tramadol—Nausea—Montelukast—chronic obstructive pulmonary disease	6.66e-05	0.000295	CcSEcCtD
Tramadol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.58e-05	0.000292	CcSEcCtD
Tramadol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.56e-05	0.000291	CcSEcCtD
Tramadol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000286	CcSEcCtD
Tramadol—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.42e-05	0.000285	CcSEcCtD
Tramadol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.39e-05	0.000283	CcSEcCtD
Tramadol—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000282	CcSEcCtD
Tramadol—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000281	CcSEcCtD
Tramadol—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.00028	CcSEcCtD
Tramadol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000276	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.2e-05	0.000275	CcSEcCtD
Tramadol—Shock—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.00027	CcSEcCtD
Tramadol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.05e-05	0.000268	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6e-05	0.000266	CcSEcCtD
Tramadol—Eye disorder—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000263	CcSEcCtD
Tramadol—Flushing—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000261	CcSEcCtD
Tramadol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000255	CcSEcCtD
Tramadol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000254	CcSEcCtD
Tramadol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.000251	CcSEcCtD
Tramadol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.61e-05	0.000249	CcSEcCtD
Tramadol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.57e-05	0.000247	CcSEcCtD
Tramadol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.000246	CcSEcCtD
Tramadol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000245	CcSEcCtD
Tramadol—Erythema—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000245	CcSEcCtD
Tramadol—Pain—Prednisolone—chronic obstructive pulmonary disease	5.3e-05	0.000235	CcSEcCtD
Tramadol—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000231	CcSEcCtD
Tramadol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000227	CcSEcCtD
Tramadol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.11e-05	0.000226	CcSEcCtD
Tramadol—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000226	CcSEcCtD
Tramadol—Agitation—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000225	CcSEcCtD
Tramadol—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000224	CcSEcCtD
Tramadol—Malaise—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.000221	CcSEcCtD
Tramadol—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.00022	CcSEcCtD
Tramadol—Syncope—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000219	CcSEcCtD
Tramadol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.93e-05	0.000218	CcSEcCtD
Tramadol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000215	CcSEcCtD
Tramadol—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000212	CcSEcCtD
Tramadol—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.000211	CcSEcCtD
Tramadol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000208	CcSEcCtD
Tramadol—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000208	CcSEcCtD
Tramadol—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000208	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000207	CcSEcCtD
Tramadol—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000206	CcSEcCtD
Tramadol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.57e-05	0.000202	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.0002	CcSEcCtD
Tramadol—Infection—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000198	CcSEcCtD
Tramadol—Shock—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000196	CcSEcCtD
Tramadol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000196	CcSEcCtD
Tramadol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000195	CcSEcCtD
Tramadol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000194	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000193	CcSEcCtD
Tramadol—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.00019	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000182	CcSEcCtD
Tramadol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.1e-05	0.000182	CcSEcCtD
Tramadol—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000181	CcSEcCtD
Tramadol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000179	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.000176	CcSEcCtD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.93e-05	0.00118	CbGpPWpGaD
Tramadol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.000174	CcSEcCtD
Tramadol—Rash—Prednisolone—chronic obstructive pulmonary disease	3.91e-05	0.000173	CcSEcCtD
Tramadol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.91e-05	0.000173	CcSEcCtD
Tramadol—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000172	CcSEcCtD
Tramadol—Headache—Prednisolone—chronic obstructive pulmonary disease	3.89e-05	0.000172	CcSEcCtD
Tramadol—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.88e-05	0.00117	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.86e-05	0.00116	CbGpPWpGaD
Tramadol—Constipation—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000171	CcSEcCtD
Tramadol—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.82e-05	0.00115	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.81e-05	0.00115	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.78e-05	0.00114	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.74e-05	0.00113	CbGpPWpGaD
Tramadol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.71e-05	0.000165	CcSEcCtD
Tramadol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.69e-05	0.00111	CbGpPWpGaD
Tramadol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.69e-05	0.000163	CcSEcCtD
Tramadol—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.68e-05	0.000163	CcSEcCtD
Tramadol—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.68e-05	0.00111	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.64e-05	0.0011	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.64e-05	0.00109	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.6e-05	0.00108	CbGpPWpGaD
Tramadol—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.58e-05	0.000159	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000158	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000158	CcSEcCtD
Tramadol—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.55e-05	0.00107	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.52e-05	0.00106	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.5e-05	0.00105	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.48e-05	0.00105	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.48e-05	0.00105	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.00104	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.45e-05	0.00104	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.43e-05	0.00103	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.42e-05	0.00103	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.4e-05	0.00102	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.38e-05	0.00102	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.34e-05	0.00101	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.34e-05	0.00101	CbGpPWpGaD
Tramadol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.32e-05	0.000147	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.29e-05	0.000991	CbGpPWpGaD
Tramadol—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000143	CcSEcCtD
Tramadol—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.19e-05	0.000141	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.16e-05	0.000951	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.15e-05	0.000947	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.13e-05	0.000942	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.000938	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000934	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.08e-05	0.000929	CbGpPWpGaD
Tramadol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000137	CcSEcCtD
Tramadol—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.06e-05	0.000922	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.03e-05	0.000914	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	3.03e-05	0.000912	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.03e-05	0.000911	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.99e-05	0.0009	CbGpPWpGaD
Tramadol—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000132	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.98e-05	0.000897	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.97e-05	0.000893	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.94e-05	0.000886	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.9e-05	0.000874	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.9e-05	0.000874	CbGpPWpGaD
Tramadol—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000127	CcSEcCtD
Tramadol—Rash—Prednisone—chronic obstructive pulmonary disease	2.84e-05	0.000126	CcSEcCtD
Tramadol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.84e-05	0.000126	CcSEcCtD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.82e-05	0.00085	CbGpPWpGaD
Tramadol—Headache—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000125	CcSEcCtD
Tramadol—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.82e-05	0.000848	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.81e-05	0.000847	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.8e-05	0.000844	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.76e-05	0.000832	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.76e-05	0.00083	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.7e-05	0.000814	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.69e-05	0.000811	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.68e-05	0.000807	CbGpPWpGaD
Tramadol—Nausea—Prednisone—chronic obstructive pulmonary disease	2.68e-05	0.000119	CcSEcCtD
Tramadol—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.67e-05	0.000804	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.66e-05	0.000801	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.000799	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.62e-05	0.00079	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.61e-05	0.000785	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.6e-05	0.000784	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.59e-05	0.000779	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.000775	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.55e-05	0.000767	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.55e-05	0.000766	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.52e-05	0.000758	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.43e-05	0.00073	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.42e-05	0.00073	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.42e-05	0.000728	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.41e-05	0.000726	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.41e-05	0.000726	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.39e-05	0.000721	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.38e-05	0.000716	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.33e-05	0.000701	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.29e-05	0.00069	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.29e-05	0.000688	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.29e-05	0.000688	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000679	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.25e-05	0.000677	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.16e-05	0.000651	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.15e-05	0.000648	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.15e-05	0.000648	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.12e-05	0.000639	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.000637	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.09e-05	0.000629	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.09e-05	0.000629	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.06e-05	0.000621	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.04e-05	0.000615	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.97e-05	0.000594	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.97e-05	0.000594	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.97e-05	0.000592	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.96e-05	0.000591	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.93e-05	0.000582	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.86e-05	0.000561	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.86e-05	0.000561	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.86e-05	0.00056	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.85e-05	0.000556	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.85e-05	0.000556	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.84e-05	0.000554	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.84e-05	0.000554	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.82e-05	0.000549	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.81e-05	0.000546	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.79e-05	0.000538	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.000528	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.73e-05	0.000521	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.69e-05	0.000509	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.69e-05	0.000509	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.68e-05	0.000507	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.66e-05	0.000501	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000498	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000494	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000493	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.00049	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.6e-05	0.000481	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.59e-05	0.000479	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000479	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.58e-05	0.000477	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.57e-05	0.000474	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.000462	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.51e-05	0.000455	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.00045	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.49e-05	0.000448	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.48e-05	0.000446	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.46e-05	0.00044	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.45e-05	0.000438	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.44e-05	0.000433	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.43e-05	0.00043	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.000429	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000429	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.000424	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000414	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.35e-05	0.000407	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.35e-05	0.000407	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.32e-05	0.000399	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.32e-05	0.000398	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000393	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.3e-05	0.000391	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000387	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.26e-05	0.000378	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.25e-05	0.000376	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.22e-05	0.000367	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000366	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.000363	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.18e-05	0.000357	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.000356	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.16e-05	0.00035	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.16e-05	0.00035	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.16e-05	0.000349	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000346	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.000341	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000332	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.1e-05	0.000332	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.1e-05	0.00033	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.09e-05	0.000328	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.08e-05	0.000326	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.000318	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.000318	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000314	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.04e-05	0.000313	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.000312	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000301	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.98e-06	0.000301	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.92e-06	0.000299	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.9e-06	0.000298	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.87e-06	0.000297	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.81e-06	0.000295	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.78e-06	0.000295	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.74e-06	0.000293	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.55e-06	0.000287	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.48e-06	0.000285	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.42e-06	0.000284	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.11e-06	0.000274	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.07e-06	0.000273	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.06e-06	0.000273	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.99e-06	0.000271	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.93e-06	0.000269	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.92e-06	0.000269	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.8e-06	0.000265	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.7e-06	0.000262	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.6e-06	0.000259	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.43e-06	0.000254	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.37e-06	0.000252	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.23e-06	0.000248	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.16e-06	0.000246	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.11e-06	0.000244	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.07e-06	0.000243	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.96e-06	0.00024	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.8e-06	0.000235	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.72e-06	0.000232	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.7e-06	0.000232	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.35e-06	0.000221	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.34e-06	0.000221	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.25e-06	0.000218	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.15e-06	0.000215	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.98e-06	0.00021	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.93e-06	0.000209	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.86e-06	0.000207	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	6.8e-06	0.000205	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.77e-06	0.000204	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.61e-06	0.000199	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.56e-06	0.000197	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.52e-06	0.000196	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	6.5e-06	0.000196	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.47e-06	0.000195	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.43e-06	0.000194	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.4e-06	0.000193	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.31e-06	0.00019	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.31e-06	0.00019	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.27e-06	0.000189	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.2e-06	0.000187	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.98e-06	0.00018	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.97e-06	0.00018	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.9e-06	0.000178	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.85e-06	0.000176	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.84e-06	0.000176	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.75e-06	0.000173	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.69e-06	0.000171	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.64e-06	0.00017	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.6e-06	0.000169	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.59e-06	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.44e-06	0.000164	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.4e-06	0.000163	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.38e-06	0.000162	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.32e-06	0.00016	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.3e-06	0.000159	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.06e-06	0.000152	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.94e-06	0.000149	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.86e-06	0.000146	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.82e-06	0.000145	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.77e-06	0.000144	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.73e-06	0.000143	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.58e-06	0.000138	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.55e-06	0.000137	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.49e-06	0.000135	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.42e-06	0.000133	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.36e-06	0.000131	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.33e-06	0.00013	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.17e-06	0.000126	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.12e-06	0.000124	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.09e-06	0.000123	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.06e-06	0.000122	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4e-06	0.00012	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.92e-06	0.000118	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.91e-06	0.000118	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	0.000117	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.66e-06	0.00011	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.59e-06	0.000108	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.52e-06	0.000106	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.44e-06	0.000103	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.15e-06	9.47e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.96e-06	8.91e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.71e-06	8.15e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.66e-06	8e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.54e-06	7.65e-05	CbGpPWpGaD
